by John Conrad | Jul 24, 2024 | NewsBrief
The University of Chicago’s Polsky Center for Entrepreneurship and Innovation has forged a strategic partnership with Orange Grove Bio (OGB), an integrated biopharmaceutical company, in a move set to accelerate biotech innovation and commercialization. This...
by John Conrad | Jul 19, 2024 | NewsBrief
In a strategic move to expand its specialty biopharmaceuticals portfolio, Meitheal Pharmaceuticals has acquired the North American rights to CONTEPO™ (fosfomycin for injection) from Nabriva Therapeutics. The announcement, made on July 18, 2024, marks a significant...
by John Conrad | Jul 18, 2024 | NewsBrief
GE HealthCare announced today that it has entered into an agreement to acquire the clinical artificial intelligence (AI) software business of Intelligent Ultrasound Group PLC for approximately $51 million. The acquisition aims to integrate innovative AI-driven image...
by John Conrad | Jul 17, 2024 | NewsBrief
A groundbreaking medical device designed to improve breast cancer treatment has successfully completed its first human trial. Innoblative Designs, Inc., a Chicago-based medical device company, announced on July 16, 2024, that its SIRA® RFA Electrosurgical Device was...
by John Conrad | Jun 28, 2024 | NewsBrief
AbbVie continues to bolster its immunology portfolio beyond Humira, announcing on Thursday its acquisition of early-stage biotech Celsius Therapeutics for $250 million in cash. This move aims to strengthen AbbVie’s longer-term prospects in inflammatory bowel...
